What happened
Actions of Modern (NASDAQ: MRNA) rose 6.2% on Tuesday with a bunch of good news for the biotech company.
And
Swiss health regulators have authorized Moderna’s COVID-19 vaccine for use in the country. The Swiss federal government subsequently ordered 7.5 million doses of the vaccine, with the first deliveries scheduled to begin later this month.
Moderna’s shares burst on Tuesday after several promising developments. Image source: Getty Images.
Moderna also announced a collaboration with Uber Technologies (NYSE: UBER) to raise awareness and access to your coronavirus vaccine. Uber will share vaccine safety information through its app. The two companies are also evaluating how to more seamlessly integrate travel scheduling with vaccine booking services.
“Used by millions of people every day, the Uber platform can help educate the public about vaccine safety and help eliminate transport barriers for vaccination,” said Uber CEO Dara Khosrowshahi, in a statement to press.
What now
Better yet, Moderna said on Monday that it expects immunity from its coronavirus vaccine to last at least a year. Biotechnology is also hopeful that its vaccine will prove effective against new strains of the virus, although it is still running tests to confirm that this is true.
Looking to the future, CEO Stéphane Bancel expects Moderna to deliver up to 1 billion doses – and generate up to $ 11.7 billion in vaccine sales – in 2021.